Prognostic Significance of Ras/p21 Alterations in Ovarian Cancer
Author Information
Author(s): G Scambia, V Masciullo, P Benedetti Panicil, M Marone, G Ferrandina, N Todaro, A Bellacosa, SK Jain, G Neri, A Piffanelli, S Mancuso
Primary Institution: Catholic University, Rome, Italy
Hypothesis
Can p21 protein levels and K-ras mutations serve as prognostic factors in ovarian cancer?
Conclusion
Higher levels of p21 protein are associated with shorter overall and progression-free survival in ovarian cancer patients.
Supporting Evidence
- p21 levels were significantly higher in malignant tumours compared to benign tumours.
- Patients with p21-positive tumours had a median overall survival of 20 months.
- p21 positivity was associated with shorter progression-free survival.
Takeaway
This study found that a protein called p21 can help doctors predict how well patients with ovarian cancer will do, with higher levels meaning a worse outlook.
Methodology
The study analyzed p21 expression and K-ras mutations in various ovarian cancer samples using Western blot and PCR techniques.
Limitations
The study was conducted at a single institution and may not be generalizable to all populations.
Participant Demographics
Patients undergoing surgery for ovarian cancer between 1988 and 1991.
Statistical Information
P-Value
P < 0.03
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website